Literature DB >> 34844099

Liver involvement in patients with erythropoietic protoporphyria: retrospective analysis of clinicopathological features of 5 cases.

Chang Zhao1, Jie-Xia Guan1, Da-Yang Hui1, Na-Na Zhang1, Li-Rong Lu2, Lu-Ying Tang1, Chun-Kui Shao3, Jian-Ning Chen4.   

Abstract

Erythropoietic protoporphyria (EPP) is a rare inherited disease whose morbidity is about 1:75,000 to 1:200,000. It is caused by the deficiency of porphyrin ferrochelatase (FECH). Liver involvement in EPP is even rarer. The diagnosis of EPP with liver involvement mainly relies on clinical manifestations, laboratory examinations, histopathological examinations and genetic testing, which is still a huge challenge for both clinicians and pathologists. Here, 5 cases of EPP with liver injury were collected, and the clinicopathological features of these patients were analyzed. The clinical manifestations and laboratory examinations varied from person to person, whereas the liver biopsies showed that there were dark brown deposits within the hepatocytes, Kupffer cells, bile canaliculi and the lumen of bile ducts, which was a constant finding by histopathological examination. Gene tests were conducted in two of the five cases, and the results confirmed the diagnosis. Fully understanding of the diseases can help us reduce the rate of missed diagnosis and provide proper treatment as early as possible.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Abnormal liver function; Clinicopathological features; Erythropoietic protoporphyria; Liver damage; Pigment particles

Mesh:

Substances:

Year:  2021        PMID: 34844099     DOI: 10.1016/j.anndiagpath.2021.151859

Source DB:  PubMed          Journal:  Ann Diagn Pathol        ISSN: 1092-9134            Impact factor:   2.090


  1 in total

1.  Erythropoietic Protoporphyria: You May Not Have Seen It, but It May Have Seen You.

Authors:  Larissa M Pastore; Christina W Sun; Sylvia Hsu
Journal:  Cureus       Date:  2022-03-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.